GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (OTCPK:OLYMY) » Definitions » Total Liabilities

Olympus (Olympus) Total Liabilities : $4,988 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Olympus Total Liabilities?

Olympus's Total Liabilities for the quarter that ended in Dec. 2023 was $4,988 Mil.

Olympus's quarterly Total Liabilities declined from Jun. 2023 ($5,527.44 Mil) to Sep. 2023 ($5,345.01 Mil) and declined from Sep. 2023 ($5,345.01 Mil) to Dec. 2023 ($4,988.11 Mil).

Olympus's annual Total Liabilities declined from Mar. 2021 ($7,249.12 Mil) to Mar. 2022 ($7,139.95 Mil) and declined from Mar. 2022 ($7,139.95 Mil) to Mar. 2023 ($6,486.95 Mil).


Olympus Total Liabilities Historical Data

The historical data trend for Olympus's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Total Liabilities Chart

Olympus Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,405.47 5,978.65 7,249.12 7,139.95 6,486.95

Olympus Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,833.46 6,486.95 5,527.44 5,345.01 4,988.11

Olympus Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Olympus's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3455.612+(2170.265+708.335
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+152.741)
=6,487

Total Liabilities=Total Assets (A: Mar. 2023 )-Total Equity (A: Mar. 2023 )
=11284.3-4797.347
=6,487

Olympus's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2638.915+(1560.742+658.37
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+130.086)
=4,988

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=10196.296-5208.183
=4,988

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus Total Liabilities Related Terms

Thank you for viewing the detailed overview of Olympus's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus (Olympus) Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (Olympus) Headlines

From GuruFocus

Olympus Announces Leadership Succession Plan

By ACN Newswire ACN Newswire 10-21-2022

Hennessy Japan Fund Goes 1 for 1 in 3rd Quarter

By Sydnee Gatewood Sydnee Gatewood 10-01-2020

Matthews Japan Fund Comments on Olympus

By Sydnee Gatewood Sydnee Gatewood 01-25-2021